After making Forbes list for the next billion-dollar startup, anxious investors are hoping a Ginkgo Bioworks IPO is in the works.
That's because biotech and healthcare IPOs are netting investors gains as much as 300% so far in 2017.
by Jack Delaney
After making Forbes list for the next billion-dollar startup, anxious investors are hoping a Ginkgo Bioworks IPO is in the works.
That's because biotech and healthcare IPOs are netting investors gains as much as 300% so far in 2017.
by Stephen Mack
Here's a look at the biggest recent IPO movers for the week of June 26-30, 2017. ObsEva and Kadmon Holdings are repeat winners, while BeyondSpring takes the top spot.
Two pharmaceutical companies, both coming off all-time highs, lead the losers list.